Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
U.S. Stem Cell Logo
U.S. Stem Cell Growth Score
21
CB Rank
275256
Heat Score
48
U.S. Stem Cell is a provider of novel regenerative medicine and autologous cellular therapies for the treatment of degenerative conditions.
Founded
obfuscation
PublicPost-IPO Debt Sunrise, Florida, United States11-50 us-stemcell.com/
Biotechnology
Health Care
Professional Services
Overview

U.S. Stem Cell
Total Funding
obfuscation
Growth Score
21
Heat Score
48

Total Funding
obfuscation
obfuscation
Post-IPO Debt raised
obfuscation
Growth Score21
-2 pts
in past quarter
Heat Score 48
-14 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
See more interactive data and historical milestones on desktop for the best experience

About U.S. Stem Cell

CB Rank
275256
U.S. Stem Cell is a provider of novel regenerative medicine and autologous cellular therapies for the treatment of degenerative conditions.
Founded
obfuscation
PublicPost-IPO Debt Sunrise, Florida, United States11-50 us-stemcell.com/
Biotechnology
Health Care
Professional Services

Funding Rounds

Post-IPO Debt
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation

Key People

Details

Legal Name U.S. Stem Cell, Inc.
Operating Status Active
Stock Symbol  OTCPINK:USRM
Company Type For Profit
Founders  William P. Murphy
About the Company

US Stem Cell is a biotechnology company engaged in the discovery, development of autologous cell therapies for the treatment of chronic and acute heart damage. Its product includes MyoCell, a clinical therapy designed to populate regions of scar tissue within a patient's heart with autologous muscle cells, or cells from a patient's body,

for the purpose of improving cardiac function in chronic heart failure patients. The company's discoveries include multiple cell therapies in various stages of development that repair damaged tissues throughout the body due to injury or disease so that patients may return to a normal lifestyle.

Phone Number 954-835-1500
Contact Email usstemcell@us-stemcell.com
Predictions & Insights

Products & Services

Adipocell™
A proprietary stem cell kit that isolates stem cells from a patient's own fat tissue for use in regenerative treatments.
Physician Training Programs
Accredited training programs that educate physicians on performing bone marrow and adipose-derived stem cell protocols.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 4
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Debt - U.S. Stem Cell Logo
Post-IPO Debt - U.S. Stem Cell
—
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - U.S. Stem Cell Logo
Post-IPO Debt - U.S. Stem Cell
—
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - U.S. Stem Cell Logo
Post-IPO Debt - U.S. Stem Cell
—
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - U.S. Stem Cell Logo
Post-IPO Debt - U.S. Stem Cell
—
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - U.S. Stem Cell Logo
Post-IPO Debt - U.S. Stem Cell
—
obfuscation
— Post-IPO Debt

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 4
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Debt - U.S. Stem Cell Logo
Post-IPO Debt - U.S. Stem Cell
—
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - U.S. Stem Cell Logo
Post-IPO Debt - U.S. Stem Cell
—
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - U.S. Stem Cell Logo
Post-IPO Debt - U.S. Stem Cell
—
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - U.S. Stem Cell Logo
Post-IPO Debt - U.S. Stem Cell
—
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - U.S. Stem Cell Logo
Post-IPO Debt - U.S. Stem Cell
—
obfuscation
— Post-IPO Debt

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 2 Contacts 4

Employee Profiles

News

News and Press

News•Mar 29, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Mar 29, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Dec 11, 2023
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Oct 23, 2023
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

IT Spend

$6.3KThis year, U.S. Stem Cell is projected to spend $6.3K on IT, according to Aberdeen.

Interest Signals

TopicSurge Score
Branded Apparel Logo
Branded Apparel
87
Forbes Logo
Forbes
79
Brand Design Logo
Brand Design
77

Actively Used Products

11U.S. Stem Cell uses 11 technology products and services including HTML5, Wordpress, and  Google Fonts, according to G2 Stack.

Total IP

1U.S. Stem Cell has 1 registered trademark in the 'Education; entertainment' class, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is U.S. Stem Cell's headquarters? U.S. Stem Cell is located in Sunrise, Florida, United States.When was the last funding round for U.S. Stem Cell? U.S. Stem Cell closed its last funding round on
obfuscation
from a Post-IPO Debt round.Who are U.S. Stem Cell's competitors? Alternatives and possible competitors to U.S. Stem Cell may include Gallant, BioXcellerator, and  Global Regenerative Academy.How much funding has U.S. Stem Cell raised to date? U.S. Stem Cell has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(2e7868f 1)
|